113 related articles for article (PubMed ID: 16737146)
1. [Screening for colorectal carcinoma in the region surrounding the city of Frýdek-Místek between 1999 - 2001].
Urban O; Chalupa P; Reha J; Orhalmi J; Hájek A; Paiger K; Vasutová I; Garcic A; Bubeník B
Vnitr Lek; 2002 Oct; 48(10):962-5. PubMed ID: 16737146
[TBL] [Abstract][Full Text] [Related]
2. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
3. Results of screening for colorectal carcinoma in the District of Bruntál using the Haemoccult Test in 1985-1988.
Zoubek V; Zoubková H
Czech Med; 1990; 13(2-3):52-7. PubMed ID: 2245757
[TBL] [Abstract][Full Text] [Related]
4. [Results of screening for colorectal carcinoma in the Bruntál District using the Haemoccult Test 1985-1986].
Zoubek V; Zoubková H
Cas Lek Cesk; 1989 Apr; 128(15):460-2. PubMed ID: 2736587
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening in the Czech Republic.
Zavoral M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
[TBL] [Abstract][Full Text] [Related]
6. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
7. [Screening of the sporadic colorectal cancer].
Zavoral M; Závada F
Cas Lek Cesk; 2007; 146(12):950-4. PubMed ID: 18257413
[TBL] [Abstract][Full Text] [Related]
8. [Repeat screening for colorectal carcinoma in a population of asymptomatic individuals after 2 years].
Zoubek V; Zoubková H
Cas Lek Cesk; 1989 Apr; 128(15):463-4. PubMed ID: 2736588
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.
Abdul Fattah AS; Nakama H; Kamijo N
Eur J Med Res; 1997 Aug; 2(8):361-4. PubMed ID: 9262491
[TBL] [Abstract][Full Text] [Related]
10. [Problems in the early diagnosis and treatment of colorectal carcinoma and adenoma in the aged].
Zoubek V; Zoubková H; Mrůzek M
Vnitr Lek; 1990 Oct; 36(10):998-1001. PubMed ID: 2256262
[TBL] [Abstract][Full Text] [Related]
11. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
12. [The screening of sporadic colorectal cancer].
Zavoral M
Vnitr Lek; 2004 Oct; 50 Suppl 1():S103-6. PubMed ID: 15651152
[TBL] [Abstract][Full Text] [Related]
13. The importance of self-observation of fecal blood in indicating a proper bowel examination.
Hákkinen IP; Nylamo EI; Sóderstróm KO
Cancer Detect Prev; 1997; 21(3):267-72. PubMed ID: 9167044
[TBL] [Abstract][Full Text] [Related]
14. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
15. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.
van Rossum LG; van Rijn AF; van Munster IP; Jansen JB; Fockens P; Laheij RJ; Dekker E
Neth J Med; 2009 May; 67(5):182-6. PubMed ID: 19581668
[TBL] [Abstract][Full Text] [Related]
16. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
17. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
18. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
19. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
20. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
